How are arrhythmias detected by implanted cardiac devices managed in Europe? Results of the European Heart Rhythm Association Survey

Europace

Volumn 17, Issue 9, 2015, Pages 1449-1453

  Todd, Derick ^a   Hernandez Madrid, Antonio ^b   Proclemer, Alessandro ^c   Bongiorni, Maria Grazia ^d   Estner, Heidi ^e   Blomström Lundqvist, Carina ^f  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY HOSPITAL OF PISA   (Italy)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

EHRA survey; EP wire; Implantable cardiac defibrillator; Implantable loop recorder; Pacemaker

Indexed keywords

ANTERIOR MYOCARDIAL INFARCTION; ATRIAL FIBRILLATION; BRADYCARDIA; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVERSION; CHADS2 SCORE; COMPLETE HEART BLOCK; ECHOCARDIOGRAPHY; EUROPE; HEALTH CARE SURVEY; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HIGH VOLUME HOSPITAL; HUMAN; IMPLANTABLE CARDIAC MONITOR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICAL SOCIETY; MONOMORPHIC VENTRICULAR TACHYCARDIA; PACEMAKER IMPLANTATION; PRIMARY PREVENTION; PRIORITY JOURNAL; QRS COMPLEX; REVIEW; CATHETER ABLATION; CLINICAL PRACTICE; CLINICAL TRIAL; MULTICENTER STUDY; PROCEDURES; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; TACHYCARDIA, VENTRICULAR;

ATRIAL FIBRILLATION; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; EUROPE; HUMANS; PRACTICE PATTERNS, PHYSICIANS'; SOCIETIES, MEDICAL; SURVEYS AND QUESTIONNAIRES; TACHYCARDIA, VENTRICULAR;

EID: 84943425470     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv310     Document Type: Review

References (12)

1. Aurichio A, Kuck KH, Hatala R, Arribas F. The EHRAWhite Book 2013: the current status of cardiac electrophysiology in ESC member countries. http://www.escardio. org/communities/EHRA/publications/Documents/ehra-white-book-2013.pdf.
2. BrignoleM, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2013;34:2281-329.
3. Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation 2012;125:2566-71.
4. Dagres N, Grazia Bongiorni M, Dobreanu D, Madrid A, Svendsen JH, Blomstrom-Lundqvist C. Current investigation and management of patients with syncope: results of the European Heart Rhythm Association survey. Europace 2013;15: 1812-5.
5. Torp-Pedersen C, Kay GN, Kalman J, Borggrefe M, Della-Bella P, Dickfeld T et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace 2014; 16:1257-83.
6. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003;107:1614-9.
7. Glotzer TV, Daoud EG, Wyse G, Singer DE, Ezekowitz MD, Hilker C et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2009; 2:474-80.
8. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120-9.
9. Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009;20:241-8.
10. Boriani G, Glotzer TV, Santini M, West TM, De Melis M, Sepsi M et al. Devicedetected atrial fibrillation and risk for stroke: an analysis of .10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J 2014;35:508-16.
11. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiological assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978;28:973-7.
12. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.